CTOs on the Move

Bedrock Communications

www.facilitiesonline.com

 
Bedrock Communications is a New York, NY-based company in the Business Services sector.
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details

Similar Companies

Dealership Systems Consultants

Dealership Systems Consultants is a Highland, CA-based company in the Business Services sector.

Metric and Multistandard Components

Metric and Multistandard Components Corp. is a Hawthorne, NY-based company in the Business Services sector.

Weber and Associates

Weber and Associates, L.C. is a Houston, TX-based company in the Business Services sector.

Tyler Flood & Associates

Have you or someone you know been charged with driving under the influence of drugs or alcohol? Its imperative you gain legal representation as soon as possible. You could face serious penalties such as license suspension, community service, steep fines, and even incarceration. Stay ahead of your charges and contact the attorneys at Tyler Flood & Associates. We thoroughly understand the laws and legal ramifications of DWI. Our attorneys will stand by your side to guide you through this legal process. We will investigate your case to find the best possible defense for you. No challenge is too big for Tyler Flood & Associates, so call us today.

Sequel Med Tech

Sequel Med Tech is a healthcare technology company based in Manchester, New Hampshire, dedicated to advancing drug delivery systems for diabetes management. The company focuses on creating innovative insulin delivery solutions that enhance the lives of people with diabetes. Their flagship product, the twiist™ Automated Insulin Delivery (AID) System, features advanced technology for precise insulin delivery and is designed for everyday wear. This system utilizes the Loop algorithm to automatically adjust insulin delivery, providing clinically meaningful benefits. Sequel Med Tech collaborates with healthcare providers, employers, and pharmaceutical companies to improve access to insulin therapy and develop new drug delivery solutions. They are actively working on integrating their twiist AID System with Abbott’s glucose-ketone sensor to enhance early detection of rising ketones, aiming to reduce the risk of diabetic ketoacidosis in individuals with type 1 diabetes. Through these efforts, Sequel Med Tech strives to simplify diabetes care and improve health outcomes for those who require insulin therapy.